Click here to search courses using NAPNAP's previous Course Catalog layout.
Title
Category
Credits
Event date
Cost
- FREE for Members
- Infectious Disease
- Pharmacology CE
- 0.25 Contact hours
$0.00
0.25 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members.
This session will review evidence-based practice for the diagnosis and treatment of skin and soft tissue infections in children. Review the key clinical diagnostic features for skin and soft tissue infections. Apply this knowledge to clinical case scenarios.
- FREE for Members
- Infectious Disease
- Pharmacology CE
- 0.50 Contact hours
$0.00
0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members.
This session will review evidence-based practice for the diagnosis and treatment of C.diff in children in ambulatory care. Apply this knowledge to clinical case scenarios.
- FREE for Members
- Infectious Disease
- Pharmacology CE
- 0.50 Contact hours
$0.00
0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members.
This session will review evidence-based practice for the diagnosis and treatment of community acquired pneumonia in children in the ambulatory care environment. Apply this knowledge to clinical case scenarios.
- FREE for Members
- Infectious Disease
- Pharmacology CE
- 0.50 Contact hours
$0.00
0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members.
This session will review evidence-based practice for the diagnosis and treatment of acute otitis media in children in ambulatory care. Learn about the value of delayed prescribing of antibiotics. Apply this knowledge to clinical case scenarios.
- FREE for Members
- Infectious Disease
- Pharmacology CE
- 0.50 Contact hours
$0.00
0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members.
This session will review the epidemiology and etiology of common tick-borne illnesses across the United States. The common presentations of various tick-borne infections are included. Clinical case scenarios are utilized to demonstrate appropriate diagnosis and treatment of tick-borne illnesses.
- Primary Care
- FREE for Members
- Pharmacology CE
- 1.00 Contact hours
$10.00
1.0 NAPNAP contact hour of which 1.0 contain pharmacology content. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Sickle cell disease (SCD) is a lifelong disease requiring expensive treatment for management and limited curative options until the last few years. Gene therapy has emerged as a curative option for SCD, with two approved therapies available to SCD patients aged greater than 12 years. Consideration must be considered regarding the ethics, efficacy, management requirements, education, and counseling needs of patients and their parents. Current and future practices will need to advocate for improved access and affordability of this specialized care and address the unknown and less defined areas of gene therapy pertaining to SCD through research.
J Pediatr Health Care. (2025) 39, Issue 1, 122-128.
- FREE for Members
- Infectious Disease
- 0.75 Contact hours
$0.00
0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and non-members.
Emerging Health Threats in Infants: Perinatal Hepatitis C.
- FREE for Members
- Infectious Disease
- 0.75 Contact hours
$0.00
0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and non-members.
- FREE for Members
- Pharmacology CE
- Psychopharmacology CE
- Controlled Substances CE
- 1.00 Contact hours
$10.00
1.0 NAPNAP contact hour of which 1.0 contain pharmacology content (Rx), (1.0 is related to psychopharmacology), (0.25 is related to controlled substance). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10.
Attention Deficit Hyperactivity Disorder (ADHD) is the most common mental health disorder among children and adolescents, with a prevalence rate of 9.8% in children 3 to 17 years of age (Bitsko et al., 2022). The American Academy of Pediatrics (AAP) has published guidelines for treatment of ADHD in children and adolescents ages 4 to 17 years that address diagnosis, treatment and monitoring of ADHD (Wolraich et al., 2019). The AAP guidelines do not address treatment of children with co-morbidities but identify the treatment of ADHD in children with comorbidities as an area for future research. To address this gap, a review of ADHD treatment in children with comorbidities including anxiety, depression, substance use disorder (SUD), epilepsy, tic disorders (TD), oppositional defiant disorder (ODD), learning disabilities (LD), autism spectrum disorder (ASD) and sleep disorders was conducted.
J Pediatr Health Care. (2025) 39, 318-325.
- Primary Care
- Mental Health
- FREE for Members
- 0.75 Contact hours
$10.00
1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. This article explores the data and practice evidence for lethal means restriction and counseling, focusing on clinical strategies and policy changes to reduce access to lethal means. Emphasis is given to how pediatric providers speak with parents about the importance of restricting access when developing a safety plan. J Pediatr Health Care. (2025) 39, 308-317.